Acorn Bioventures gathers nearly $200m for maiden fund

Acorn Bioventures has raised $199.5 million for its debut fund, according to an SEC filing.

27 March 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles